![Jan Peter Olofsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan Peter Olofsson
Gründer bei
Redoxis AB
Profil
Peter Olofsson is the founder of Redoxis AB, founded in 2007, holding the title of Director.
Dr. Olofsson is currently the Chief Executive Officer of ProNoxis AB since 2012.
Former positions include Principal at Biovitrum AB and Principal at Arexis AB. Education includes a doctorate from the University of Lund and an MBA from the University of Gothenburg.
Aktive Positionen von Jan Peter Olofsson
| Unternehmen | Position | Beginn |
|---|---|---|
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Gründer | 01.01.2007 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jan Peter Olofsson
| Unternehmen | Position | Ende |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Direktor/Vorstandsmitglied | 31.12.2009 |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Jan Peter Olofsson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
